Related Experiment Videos
Insights
Home oxygen therapy enabled early discharge for infants with Bronchopulmonary dysplasia (BPD). This provided significant cost savings and improved family environments for affected infants.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
- Long-term hospitalization is common for infants with BPD, impacting families and healthcare costs.
Purpose of the Study:
- To evaluate the feasibility and outcomes of home oxygen therapy for infants with BPD.
- To assess the impact of home oxygen on infant discharge timing, family environment, and cost savings.
Main Methods:
- A cohort of six infants diagnosed with BPD received home oxygen therapy.
- Clinical outcomes and hospital discharge data were retrospectively reviewed.
Main Results:
- Home oxygen therapy was successfully implemented in all six infants without complications.
- Early discharge was facilitated, leading to an average cost saving of $18,000 per infant.
- A more normalized family environment was achieved for the infants receiving home care.
Conclusions:
- Home oxygen therapy is a safe and effective option for select infants with BPD.
- Implementing home oxygen programs can lead to substantial financial savings and improved quality of life for infants and their families.
Abstract:
Home oxygen was utilized in six infants with BPD with no complications. This program allowed for early discharge of the infants, resulting in a mean financial savings of $18,000 per infant and a more normal family environment for the babies.